Show HN: Foundation models that predict patient response in clinical trials

A foundational model of patient biology predicts response to ustekinumab in ulcerative colitis at AUROC 0.76 — and reframes how a clinical trial is sized.

View Post on Scour ↗

More from atlasdiscovery.bio on Scour.

Discussed on Hacker News